LifeMD outlines $192M-$193M 2025 revenue target amid margin shifts and expansion into women's and behavioral health [Seeking Alpha]
LifeMD, Inc. (LFMD)
Company Research
Source: Seeking Alpha
CEO Justin Schreiber reported significant progress on strategic initiatives, stating "Our RexMD business returned to growth adding approximately 10,000 net new subscribers, and our weight management offering has stabilized and is now well Quick Insights Management anticipates foundational investments and focus on women's and behavioral health will accelerate growth, aided by expanded pharmacy capabilities and partnerships, positioning LifeMD for significant gains in 2026. Intense competition from low-cost compounded GLP-1 rivals and margin pressures due to revenue mix shifts present key risks, with management expecting slightly lower gross margins, especially as compounded therapies undercut branded prices. Insurance coverage reduces customer acquisition costs by over a third and is expected to support subscriber growth once available, potentially improving margins and driving adoption in core therapy areas. More Trending News
Show less
Read more
Impact Snapshot
Event Time:
LFMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFMD alerts
High impacting LifeMD, Inc. news events
Weekly update
A roundup of the hottest topics
LFMD
News
- LifeMD (NASDAQ:LFMD) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- LifeMD (NASDAQ:LFMD) was given a new $8.00 price target on by analysts at Loop Capital.MarketBeat
- LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026GlobeNewswire
- LifeMD (NASDAQ:LFMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.MarketBeat
- LifeMD: WorkSimpli Divestment Creates Virtual Care Pure Play [Seeking Alpha]Seeking Alpha
LFMD
Earnings
- 11/17/25 - Miss
LFMD
Sec Filings
- 11/24/25 - Form 144
- 11/17/25 - Form 10-Q
- 11/17/25 - Form 8-K
- LFMD's page on the SEC website